Ra Pharmaceuticals Inc

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Acceleration Bands

Score

-0.25

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 47 6.5 0.40% 0.68% 10.4% -4.6% 70.2%
SHORT 46 10.9 0.28% 0.37% 7.1% -5.4% -97.4%

Summary

Technical Analysis

Ra Pharmaceuticals Inc (RARX)


Indicator:

ACCELERATION BANDS


Last Signal:

BULLISH


Trading: BUY @ $46.9
Signal Strength: STRONG
Recommendation:

Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.


Ra Pharmaceuticals Inc (NASDAQ:RARX) is currently Oversold highlighting the potential for a short term trend reversal in the upward direction.



Acceleration bands serve as a trading envelope using an instrument’s typical volatility over a standard setting of 20 bars. The user may change the input (close) period length and multiplier factor.

Calculation: Acceleration Bands:
1) Upper band = ( High * ( 1 + 2 * (((( High – Low )/(( High + Low ) / 2 )) * 1000 ) * Factor )));
2) Lower band = ( Low * ( 1 – 2 * (((( High – Low )/(( High + Low ) / 2 )) * 1000 ) * Factor )));
3) Where Factor=0.001


PROFILE: Ra Pharmaceuticals Inc (RARX)


Stock Exchange: NASDAQ
Company: Ra Pharmaceuticals Inc
Ticker Codes: | RARX | NASDAQ:RARX |

About Ra Pharmaceuticals Inc (NASDAQ:RARX):

Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system in the United States. The company's peptide chemistry platform enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. Its lead product candidate is RA101495, an injection into the tissue under the skin that has completed Phase II clinical trial for the treatment of paroxysmal nocturnal hemoglobinuria (PNH); and is in Phase II clinical trial for treating patients with generalized myasthenia gravis (gMG), as well as in Phase 1b clinical trial for treating atypical hemolytic uremic syndrome (aHUS) and lupus nephritis (LN). The company's preclinical testing products include Factor D inhibition for orphan renal and dense deposit diseases, and C3 glomerulonephritis; Oral C5 inhibitor for PNH, gMG, aHUS, LN, and central nervous system (CNS) diseases; and other complement inhibitors for autoimmune/CNS diseases. It has multi-target collaboration and license agreement with Merck & Co., Inc. Ra Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Top 10:

Acceleration Bands

Download
Company Close Change(%) Volume Value Signal
TLGT Teligent 0.42 5.5 1,235,129 -7.45 BEARISH
SYRS Syros Pharmaceuticals 8.2 4.9 153,243 -6.07 BEARISH
FARM Farmer Brothers 13.38 4.4 116,584 -1.89 BEARISH
TRUP Trupanion Inc 33.32 4.2 261,897 -6.24 BEARISH
CYTK Cytokinetics 12.54 3.3 413,412 -0.05 BEARISH
BCOR Blucora Inc 23.41 3.2 401,986 -7.71 BEARISH
OTIC Otonomy Inc 3.65 3.1 161,652 -2.67 BEARISH
VSEC VSE Corporation 34.74 3 14,243 -4.91 BEARISH
VRAY Viewray Inc 3.06 3 3,697,594 -11.21 BEARISH
ACIU AC Immune 9.65 2.7 62,564 -0.92 BEARISH